Related Experiment Videos

Protein kinase C in disease: cancer

Alan P Fields¹, W Clay Gustafson

¹The Mayo Clinic Cancer Center, Jacksonville, FL, USA.

Methods in Molecular Biology (Clifton, N.J.)

|July 4, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

Nature medicine·2026

PRKCI-ECT2 copy number gain promotes developmental reprogramming and metastatic competence in lung adenocarcinoma.

Cell reports·2026

Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase Cβ.

Nature communications·2026

Protein kinase Cι dictates tumor trajectory, cell plasticity, and immune surveillance in lung adenocarcinoma.

Cell reports·2025

A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer.

American journal of clinical oncology·2025

The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

See all related articles